Health Prob Civil. 2024; 18(3): 259-272.
1. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020; 10(1): 14790. https://doi.org/10.1038/s41598-020-71908-9
2.
World Health Organization. Diabetes [Internet]. Geneva: WHO; 2023 [access 2023 July 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
3.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-281. https://doi.org/10.1016/j.diabres.2018.02.023
4.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119. https://doi.org/10.1016/j.diabres.2021.109119
5.
Tabesh M, Shaw JE, Zimmet PZ, Söderberg S, Koye DN, Kowlessur S, et al. Association between type 2 diabetes mellitus and disability: what is the contribution of diabetes risk factors and diabetes complications?. J Diabetes. 2018; 10(9): 744-752. https://doi.org/10.1111/1753-0407.12659
6.
Magliano DJ, Martin VJ, Owen AJ, Zomer E, Liew D. The productivity burden of diabetes at a population level. Diabetes Care. 2018; 41(5): 979-984. https://doi.org/10.2337/dc17-2138
7.
Galaviz KI, Weber MB, Straus A, Haw JS, Narayan KM, Ali MK. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care. 2018; 41(7): 1526-1534. https://doi.org/10.2337/dc17-2222
8.
Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017; 177(12): 1808-1817. https://doi.org/10.1001/jamainternmed.2017.6040
9.
Sun Y, You W, Almeida F, Estabrooks P, Davy B. The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis. J Acad Nutr Diet. 2017; 117(3): 404-421. https://doi.org/10.1016/j.jand.2016.11.016
10.
Primavera M, Giannini C, Chiarelli F. Prediction and prevention of type 1 diabetes. Front Endocrinol (Lausanne). 2020; 11: 248. https://doi.org/10.3389/fendo.2020.00248
11.
Beik P, Ciesielska M, Kucza M, Kurczewska A, Kuźmińska J, Maćkowiak B, et al. Prevention of type 1 diabetes: past experiences and future opportunities. J Clin Med. 2020; 9(9): 2805. https://doi.org/10.3390/jcm9092805
12.
Afable A, Karingula NS. Evidence based review of type 2 diabetes prevention and management in low and middle income countries. World J Diabetes. 2016; 7(10): 209-229. https://doi.org/10.4239/wjd.v7.i10.209
13.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018; 14(2): 88-98. https://doi.org/10.1038/nrendo.2017.151
14.
Ismail L, Materwala H, Al Kaabi J. Association of risk factors with type 2 diabetes: a systematic review. Comput Struct Biotechnol J. 2021; 19: 1759-1785. https://doi.org/10.1016/j.csbj.2021.03.003
15.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for prediabetes and type 2 diabetes: us preventive services task force recommendation statement. JAMA. 2021; 326(8): 736-743. https://doi.org/10.1001/jama.2021.12531
16.
Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP. Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med. 2014; 47(4): 375-381. https://doi.org/10.1016/j.amepre.2014.05.012
17.
Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017; 8(4): 120-129. https://doi.org/10.4239/wjd.v8.i4.120
18.
Organisation for Economic Cooperation and Development. Health at a Glance: Europe 2020: State of Health in the EU Cycle [Internet]. Paris: OECD; 2021 [access 2023 July 24]. Available from: https://www.oecd-ilibrary.org/sites/83231356-en/index.html?itemId=/content/component/83231356-en
19.
Topor-Madry R, Wojtyniak B, Strojek K, Rutkowski D, Bogusławski S, Ignaszewska-Wyrzykowska A, et al. Prevalence of diabetes in Poland: a combined analysis of national databases. Diabet Med. 2019; 36(10): 1209-1216. https://doi.org/10.1111/dme.13949
20.
Towpik I, Walicka M, Marcinkowska K, Lisicka I, Raczyńska M, Wierzba W, et al. Epidemiology of diabetes in Poland in 2014-2017. Clinical Diabetology. 2020; 9(5): 279-285.
21.
Chancellery of the Prime Minister. [Regulation on the National Health Program for 2021-2025] [Internet]. Warszawa: KPRM; 2023 [access 2023 Jul 24]. Available from: https://www.gov.pl/web/premier/rozporzadzenie-w-sprawie-narodowego-programu-zdrowia-na-lata-2021-2025 (in Polish).
22.
Ladner A, Keuffer N, Baldersheim H. Measuring local autonomy in 39 countries (1990-2014). Regional & Federal Studies. 2016; 26(3): 321-357. https://doi.org/10.1080/13597566.2016.1214911
23.
Kurowska P, Królak A, Giermaziak W. Health policy programs realised in Poland in 2016-2017. Rocz Panstw Zakl Hig. 2018; 69(2): 209-217.
24.
Lipska I, McAuslane N, Leufkens H, Hövels A. A decade of health technology assessment in Poland. Int J Technol Assess Health Care. 2017; 33(3): 350-357. https://doi.org/10.1017/S0266462317000563
25.
Agency for Health Technology Assessment and Tariff System. Health policy programmes [Internet]. Warszawa: AOTMiT; 2023 [access 2023 Jul 24]. Available from: https://www.aotm.gov.pl/en/healthpolicy-programmes/
26.
Statistics Poland. Administrative division of Poland [Internet]. Warszawa: GUS; 2023 [access 2023 Jul 24]. Available from: https://stat.gov.pl/en/regional-statistics/classification-of-territorial-units/administrative-division-of-poland/
27.
Pluta A, Marzec A, Kobus E, Sulikowska B. Main aspects of preparing diabetic patients in poland for selfcare. Int J Environ Res Public Health. 2022; 19(18): 11365. https://doi.org/10.3390/ijerph191811365
28.
Pawlak-Sobczak K, Drygas W, Kwaśniewska M, Dziankowska-Zaborszczyk E, Pająk A, Kozakiewicz K, et al. The level of knowledge of diabetic prevention in Poland – is there a phenomenon of pluralistic ignorance?. Int J Occup Med Environ Health. 2021; 34(5): 667-678. https://doi.org/10.13075/ijomeh.1896.01746
29.
Agency for Health Technology Assessment and Tariff System. [Opinion on health policy programmes] [Internet]. Warszawa: AOTMiT; 2023 [access 2023 July 24]. Available from: https://bipold.aotm.gov.pl/index.pHPP/repozytorium-ppz-2/opinie-o-projektach-programow-zdrowotnych-realizowanych-przezjst (in Polish).
30.
Ministry of Health. [National Health Program 2021-2025] [Internet]. Warszawa: MZ; 2023 [access 2023 Jul 24]. Available from: https://www.gov.pl/web/zdrowie/narodowy-program-zdrowia-2021-2025 (in Polish).
31.
Polish Supreme Audit Office. [Information on the results of the audit „Implementation of tasks of the National Health Program for 2016-2020”] [Internet]. Warszawa: NIK; 2021 [access 2023 Jul 24]. Available from: https://www.nik.gov.pl/kontrole/wyniki-kontroli-nik/pobierz,kzd~p_19_060_201908121140451565602845~01,typ,kk.pdf (in Polish).
32.
Augustynowicz A, Borowska M, Lewtak K, Borowicz J, Waszkiewicz M, Karakiewicz B, et al. Financing of immunization programs by local government units in Poland as an element of health policy. Vaccines (Basel). 2021; 10(1): 28. https://doi.org/10.3390/vaccines10010028
33.
Jones A, Wu JH, Buse K. UK’s sugar tax hits the sweet spot. BMJ. 2021; 372: n463. https://doi.org/10.1136/bmj.n463
34.
Augustynowicz A, Czerw AI, Deptała A. Health needs as a priority of local authorities in Poland based on the example of implementation of health policy cancer programmes. Arch Med Sci. 2018; 14(6): 1439- 1449. https://doi.org/10.5114/aoms.2016.62283
35.
Patyna M, Płusa A, Ziębińska A. [The design, assessment, implementation, monitoring and evaluation of health policy programs]. Zdr. Publiczne Zarządzanie. 2019; 17: 203-216 (in Polish). https://doi.org/10.4467/20842627OZ.19.022.12184
36.
Augustynowicz A, Bojar I, Borowska M, Bobiński K, Czerw A. Self-government HPPV vaccination programmes in Poland, 2009-2016. Ann Agric Environ Med. 2020; 27(3): 379-383. https://doi.org/10.26444/aaem/109620
37.
Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?. Health Aff. 2012; 31(1): 67-75. https://doi.org/10.1377/hlthaff.2011.1009
38.
Williamson DA. Prevention of type 2 diabetes: what is the right target population?. Expert Rev Endocrinol Metab. 2018; 13(6): 295-305. https://doi.org/10.1080/17446651.2018.1535896
39.
.Park J, Zhang P, Shao H, Laxy M, Imperatore G. Selecting a target population for type 2 diabetes lifestyle prevention programs: a cost-effectiveness perspective. Diabet Med. 2022; 39(7): e14847. https://doi.org/10.1111/dme.14847
40.
Kaur G, Lakshmi PV, Rastogi A, Bhansali A, Jain S, Teerawattananon Y, et al. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: a systematic review and meta-analysis. PLoS One. 2020; 15(11): e0242415. https://doi.org/10.1371/journal.pone.0242415
41.
Peer N, Balakrishna Y, Durao S. Screening for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020; 5(5): CD005266. https://doi.org/10.1002/14651858.CD005266.pub2
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
